Predicting 'Airborne' Influenza Viruses: (Trans-) Mission Impossible?

Total Page:16

File Type:pdf, Size:1020Kb

Predicting 'Airborne' Influenza Viruses: (Trans-) Mission Impossible? Available online at www.sciencedirect.com Predicting ‘airborne’ influenza viruses: (trans-) mission impossible? EM Sorrell1, EJA Schrauwen1, M Linster1, M De Graaf2, S Herfst1 and RAM Fouchier1 Repeated transmission of animal influenza viruses to humans transmissible via small particle aerosols (typically <5 mm) has prompted investigation of the viral, host, and environmental or large respiratory droplets (typically >5 mm), shortened factors responsible for transmission via aerosols or respiratory hereafter as airborne transmissible. droplets. How do we determine — out of thousands of influenza virus isolates collected in animal surveillance studies Influenza A viruses are constantly undergoing genetic each year — which viruses have the potential to become and phenotypic changes during their circulation in avian ‘airborne’, and hence pose a pandemic threat? Here, using and mammalian species. Our knowledge of viral traits knowledge from pandemic, zoonotic and epidemic viruses, we necessary for host switching and virulence has increased postulate that the minimal requirements for efficient significantly over the last decade. However, what transmission of an animal influenza virus between humans are: exactly determines airborne transmission of influenza efficient virus attachment to (upper) respiratory tissues, viruses in humans has remained largely unknown. Only replication to high titers in these tissues, and release and when we fully understand the viral (genetic and phe- aerosolization of single virus particles. Investigating ‘airborne’ notypic), host, and environmental factors that drive transmission of influenza viruses is key to understand — and airborne transmission can we start to make predictions predict — influenza pandemics. about which influenza viruses may cause future influ- Addresses enza pandemics. 1 National Influenza Center and Department of Virology, Erasmus Medical Center, P.O. Box 2040, 3000CA Rotterdam, The Netherlands 2 Department of Zoology, University of Cambridge, Downing Street, Past pandemics Cambridge CB2 3EJ, United Kingdom Four major pandemics have been recognized for which Corresponding author: Fouchier, viral genome sequence data is available. While it was RAM ([email protected]) initially proposed that the 1918 H1N1 Spanish influenza pandemic was caused by a wholly avian virus that adapted to humans [1], recent evidence suggests that some of its Current Opinion in Virology 2011, 1:635–642 genes were derived from mammalian viruses circulating This review comes from a themed issue on as early as 1911 [2 ]. The 1957 H2N2 Asian influenza Emerging viruses pandemic resulted from the reassortment of avian HA, Edited by JS Malik Peiris and Colin Parrish NA, and PB1 virus genes with the then circulating sea- sonal human H1N1 influenza virus [3]. The H3N2 Hong Available online 3rd September 2011 Kong influenza pandemic of 1968 was also a product of 1879-6257/$ – see front matter reassortment between avian and human virus genes; HA # 2011 Elsevier B.V. All rights reserved. and PB1 genes of the H2N2 virus were replaced by those DOI 10.1016/j.coviro.2011.07.003 of an avian H3 virus [3]. In 2009, an H1N1 influenza virus of swine origin caused the first pandemic of the 21st century [4]. The gene constellation of this virus showed clear evidence of multiple reassortment events that had Introduction presumably occurred in pigs over a period of years [5] The virus or virus subtype that will cause the next (Figure 1). The role of swine as a mixing vessel for the influenza pandemic is a highly debated topic in the field. generation of reassortant influenza A viruses with pan- Some believe that only influenza virus subtypes H1, H2, demic potential is generally accepted, yet still under- and H3 can cause pandemics in humans, and therefore — estimated (reviewed in [6]). However, it should be noted beyond isolated cases of zoonotic infections — we should that reassortment can conceivably take place in avian or not worry about virus subtypes such as H5N1, H7N7 or human hosts; for pandemics before 2009, there is no H9N2 for human health. Many believe that swine viruses, evidence that reassortment events occurred in pigs. rather than avian viruses, are more likely to cause the next Regardless of the identity of the mixing vessel it is pandemic. However, beyond the fact that there will be important to emphasize that most, if not all, recent future pandemics, there is little known in terms of the influenza pandemics were caused by reassortant viruses. viral origin, subtype, and virulence of the next pandemic. The expansion in surveillance efforts in pigs in response One other assumption can be made: the virus will be to the 2009 pandemic will most likely reveal many more www.sciencedirect.com Current Opinion in Virology 2011, 1:635–642 636 Emerging viruses Figure 1 mammalian avian seasonal human avianseasonal human avian seasonal human avianclassical swine avian H?N? H?N? H1N1 H2N2 H2N2 H3N? H3N2 H1N1 H1N1 H1N1 (PB2, PA, NP,MA, NS) (PB1, NA, HA) (PB2, PA, NP, NA, MA, NS) (PB1, HA) (PB1) (PB2, PA) (HA, NP, NS) reassortant eurasian swine H1N? H1N1 (PB2, PB1, PA, HA, NA, NS) (NA, MA) reassortant reassortant reassortant H1N1? H2N2 H3N2 reassortant H1N1 pandemic human pandemic human pandemic human pandemic human H1N1 H2N2 H3N2 H1N1 before or in 1918: before or in 1957: before or in 1968: before or in 2009: Spanish influenza Asian influenza Hong Kong influenza swine origin H1N1 pandemic H2N2 pandemic H3N2 pandemic H1N1 pandemic Current Opinion in Virology Reassortment and adaptation events of pandemic influenza A viruses. For the 1918 H1N1 ‘Spanish influenza’ pandemic, evidence for two mutually exclusive scenarios has been presented: the gradual adaptation of avian genes to the human host and a reassortment event between avian and mammalian viruses. After 1918, the H1N1 virus caused seasonal epidemics until 1957, when the H2N2 influenza A virus emerged upon reassortment between the seasonal H1N1 and an avian H2N2 virus, introducing the avian HA, NA, and PB1 genes. This H2N2 virus circulated in humans until 1968, when reassortment of the H2N2 with an avian H3 virus resulted in exchange of the H3 HA and PB1 genes to yield a new pandemic virus of subtype H3N2. The 2009 H1N1 pandemic contained the NA and M genes of the Eurasian swine lineage, and the other genes of a ‘triple reassortant’ swine influenza virus that earlier acquired its genes upon reassortment between human, avian, and (classical) swine viruses. Grey colour in virus particles indicates uncertainty of viral gene segment origin or lack of data. Dotted arrows indicate uncertain scenarios and solid arrows indicate events that are supported by scientific evidence. Dashed arrows represent pandemic viruses circulating in following influenza seasons. reassortant viruses that may or may not have the potential Viral determinants of transmission to infect and spread in humans. But how, out of thousands Retrospective analysis of pandemic H1 (1918), H2 and of animal influenza viruses from surveillance studies, can H3 viruses has revealed that only one to two mutations in we select the ones we should prepare for as potential the HA receptor binding site are required to confer causes of new pandemics? binding preference for virus receptors on cells of the Current Opinion in Virology 2011, 1:635–642 www.sciencedirect.com Predicting ‘airborne’ influenza viruses Sorrell et al. 637 upper respiratory tract (URT) of humans, a2,6-linked thought to be the mechanism behind the increase in sialic acids (SAs) [7]. Partially borrowing from this knowl- replication efficiency [20]. edge, several mutations in the HA protein, including Q222L, G224S, E186D, K189R, S223N and N182K PA and NP genes have also been associated with viral host (H5 numbering), have been shown to change and/or restriction but the key amino acids have yet to be ident- increase receptor binding of avian H9N2 and H5N1 ified. Even fewer experiments have looked at the roles of viruses to human URT tissues [8–12] with changes like NA, M and NS proteins in determining host range and Q226L (H3 numbering) improving replication and trans- transmission. It is likely that virus tropism, efficiency in mission of H9 viruses [13]. However, to date, none of the replication, amount of virus shed, and the duration of ‘designer’ H5N1 viruses carrying these mutations have shedding are important factors for transmission efficiency. resulted in airborne transmission [11,14]. Efficient H5 A longer duration of virus shedding at high titer may be transmission may thus require more subtle differences in hypothesized to increase the chance for the virus to reach receptor preference than simple a2,3 (the receptor for susceptible host(s) and therefore increase transmission avian viruses) versus a2,6 SA linkage specificity. events [21]. Previous research has also pointed to key changes in the Airborne transmission; size does matter polymerase proteins that increase virus replication effi- Human-to-human transmission of influenza viruses can ciency at 33 8C, the accepted temperature for efficient occur through contact, direct or indirect, and/or respirat- replication in the mammalian URT [15 ,16]. These ory droplets (large droplets and aerosols). Opinions differ changes at positions 627, 701 and 591 of PB2 have also on the importance of each mode of transmission been shown to support transmission of multiple subtypes (reviewed in [22,23]). The role of each has been well in mammalian models [17,18,19 ]. A decrease in associ- studied in mammalian models, focusing on the ferret
Recommended publications
  • Washington State Annual Communicable Disease Report 2008
    Washington State COMMUNICABLE DISEASE REPORT 2008 "The Department of Health works to protect and improve the health of people in Washington State." WASHINGTON STATE DEPARTMENT OF HEALTH Epidemiology, Health Statistics and Public Health Laboratories Communicable Disease Epidemiology Section 1610 NE 150th Street Shoreline, WA 98155 206-418-5500 or 1-877-539-4344 COMMUNICABLE DISEASE REPORT 2008 CONTRIBUTORS COMMUNICABLE DISEASE EPIDEMIOLOGY Rebecca Baer, MPH Katelin Bugler, MPH Mary Chadden Erin Chester, MPH Natasha Close, MPH Marisa D’Angeli, MD, MPH Chas DeBolt, RN, MPH Marcia Goldoft, MD, MPH Kathy Lofy, MD Kathryn MacDonald, PhD Nicola Marsden-Haug, MPH Judith May, RN, MPH Tracy Sandifer, MPH Phyllis Shoemaker, BA Deborah Todd, RN, MPH Sherryl Terletter Doreen Terao Wayne Turnberg, PhD, MSPH COMMUNITY AND FAMILY HEALTH Maria Courogen, MPH Kim Field, RN, MSN Salem Gugsa, MPH Tom Jaenicke, MPH, MBA, MES Shana Johnny, RN, MN Julieann Simon, MSPH i Mary Selecky Secretary of Health Maxine Hayes, MD, MPH Health Officer Dennis Dennis, PhD, RN Assistant Secretary Epidemiology, Health Statistics and Public Health Laboratories Judith May, RN, MPH Office Director for Communicable Disease Tony Marfin, MD, MPH, MA State Epidemiologist for Communicable Disease Romesh Gautom, PhD Director, Public Health Laboratories Juliet VanEenwyk, PhD, MS State Epidemiologist for Non-Infectious Disease This report represents Washington State communicable disease surveillance: the ongoing collection, analysis and dissemination of morbidity and mortality data to prevent
    [Show full text]
  • Mask Use in the Context of COVID-19 Interim Guidance 1 December 2020
    Mask use in the context of COVID-19 Interim guidance 1 December 2020 This document, which is an update of the guidance published patients wear the following types of mask/respirator in on 5 June 2020, includes new scientific evidence relevant to addition to other personal protective equipment that are the use of masks for reducing the spread of SARS-CoV-2, the part of standard, droplet and contact precautions: virus that causes COVID-19, and practical considerations. It ­ medical mask in the absence of aerosol contains updated evidence and guidance on the following: generating procedures (AGPs) • mask management; ­ respirator, N95 or FFP2 or FFP3 standards, or • SARS-CoV-2 transmission; equivalent in care settings for COVID-19 • masking in health facilities in areas with community, patients where AGPs are performed; these may cluster and sporadic transmission; be used by health workers when providing care • mask use by the public in areas with community and to COVID-19 patients in other settings if they cluster transmission; are widely available and if costs is not an issue. • alternatives to non-medical masks for the public; • In areas of known or suspected community or cluster • exhalation valves on respirators and non-medical masks; SARS-CoV-2 transmission WHO advises the following: • mask use during vigorous intensity physical activity; ­ universal masking for all persons (staff, patients, visitors, service providers and others) within the • essential parameters to be considered when health facility (including primary, secondary manufacturing non-medical masks (Annex). and tertiary care levels; outpatient care; and Key points long-term care facilities) ­ wearing of masks by inpatients when physical • The World Health Organization (WHO) advises the use distancing of at least 1 metre cannot be of masks as part of a comprehensive package of maintained or when patients are outside of their prevention and control measures to limit the spread of care areas.
    [Show full text]
  • Defining the Sizes of Airborne Particles That Mediate Influenza Transmission in Ferrets
    Defining the sizes of airborne particles that mediate influenza transmission in ferrets Jie Zhoua,1, Jianjian Weib,1, Ka-Tim Choya, Sin Fun Siaa, Dewi K. Rowlandsc, Dan Yua, Chung-Yi Wud, William G. Lindsleye, Benjamin J. Cowlinga, James McDevittf, Malik Peirisa,2, Yuguo Lib, and Hui-Ling Yena,2 aSchool of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; bDepartment of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China; cLaboratory Animal Services Centre, The Chinese University of Hong Kong, Hong Kong SAR, China; dGenomics Research Center, Academia Sinica, Taiwan, Republic of China; eAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505; and fDepartment of Environmental Health, Harvard School of Public Health, Boston, MA 02115 Contributed by Malik Peiris, January 16, 2018 (sent for review October 2, 2017; reviewed by Kanta Subbarao and Terrence M. Tumpey) Epidemics and pandemics of influenza are characterized by rapid ferrets via respiratory droplets, ferrets are often used to assess the global spread mediated by non-mutually exclusive transmission pandemic risk of zoonotic influenza viruses (11). However, the modes. The relative significance between contact, droplet, and conventional experimental settings cannot clarify the relative airborne transmission is yet to be defined, a knowledge gap for transmission efficiency of airborne particles of different sizes implementing evidence-based infection control measures. We that mediate droplet and airborne transmission. To address this devised a transmission chamber that separates virus-laden particles knowledge gap, we developed a transmission chamber capable by size and determined the particle sizes mediating transmission of separating influenza virus-laden particles into specific size of influenza among ferrets through the air.
    [Show full text]
  • Transmission of SARS-Cov-2: Implications for Infection Prevention Precautions
    Transmission of SARS-CoV-2: implications for infection prevention precautions Scientific brief 9 July 2020 This document is an update to the scientific brief published on 29 March 2020 entitled “Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precaution recommendations” and includes new scientific evidence available on transmission of SARS-CoV-2, the virus that causes COVID-19. Overview This scientific brief provides an overview of the modes of transmission of SARS-CoV-2, what is known about when infected people transmit the virus, and the implications for infection prevention and control precautions within and outside health facilities. This scientific brief is not a systematic review. Rather, it reflects the consolidation of rapid reviews of publications in peer-reviewed journals and of non-peer-reviewed manuscripts on pre-print servers, undertaken by WHO and partners. Preprint findings should be interpreted with caution in the absence of peer review. This brief is also informed by several discussions via teleconferences with the WHO Health Emergencies Programme ad hoc Experts Advisory Panel for IPC Preparedness, Readiness and Response to COVID-19, the WHO ad hoc COVID-19 IPC Guidance Development Group (COVID-19 IPC GDG), and by review of external experts with relevant technical backgrounds. The overarching aim of the global Strategic Preparedness and Response Plan for COVID-19(1) is to control COVID-19 by suppressing transmission of the virus and preventing associated illness and death. Current evidence suggests that SARS-CoV-2, the virus that causes COVID-19, is predominantly spread from person-to-person.
    [Show full text]
  • Transmissibility and Transmission of Respiratory Viruses
    REVIEWS Transmissibility and transmission of respiratory viruses Nancy H. L. Leung Abstract | Human respiratory virus infections lead to a spectrum of respiratory symptoms and disease severity, contributing to substantial morbidity, mortality and economic losses worldwide, as seen in the COVID-19 pandemic. Belonging to diverse families, respiratory viruses differ in how easy they spread (transmissibility) and the mechanism (modes) of transmission. Transmissibility as estimated by the basic reproduction number (R0) or secondary attack rate is heterogeneous for the same virus. Respiratory viruses can be transmitted via four major modes of transmission: direct (physical) contact, indirect contact (fomite), (large) droplets and (fine) aerosols. We know little about the relative contribution of each mode to the transmission of a particular virus in different settings, and how its variation affects transmissibility and transmission dynamics. Discussion on the particle size threshold between droplets and aerosols and the importance of aerosol transmission for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus is ongoing. Mechanistic evidence supports the efficacies of non-pharmaceutical interventions with regard to virus reduction; however, more data are needed on their effectiveness in reducing transmission. Understanding the relative contribution of different modes to transmission is crucial to inform the effectiveness of non-pharmaceutical interventions in the population. Intervening against multiple modes of transmission should be more effective than acting on a single mode. Human respiratory viruses include a broad range of supporting different modes of transmission will aid in viruses that infect cells of the respiratory tract, elicit the control of respiratory virus transmission. respiratory and other symptoms, and are transmitted Previous reviews and commentaries discussed the mainly by respiratory secretions of infected persons.
    [Show full text]
  • Diseases Spread Through Respiratory Secretions 1
    Diseases Spread through Respiratory Secretions 1 DISEASES SPREAD THROUGH RESPIRATORY SECRETIONS A. Introduction Many diseases are spread through the respiratory droplets that spray into the air when an infected person coughs or sneezes. These germs can spread from person-to-person, or when someone touches a surface with respiratory germs on it and then touches their mouth or nose. (See the Glossary for explanations on airborne and respiratory droplet transmission.) In this section you will find information on the following diseases: Influenza Group A streptococcus Meningococcal disease Tuberculosis (airborne spread) B. Influenza Influenza (commonly known as “the flu”) is a serious, acute respiratory infection that is caused by a virus. People of any age can get the flu. Most people who get influenza are ill for only a few days, but some people can become very sick and will need to go to an emergency room or to the doctor’s office. Please note that influenza is a reportable disease and must be reported to YRCHS for appropriate follow-up. Transmission Flu spreads easily from infected people beginning 24 hours prior to the onset of symptoms and for the first three to five days of illness in adults and for 7 to 10 days in children through coughing and sneezing. It is also spread through direct contact with contaminated surfaces, unwashed hands, or objects such as toys and eating utensils, that have been contaminated by the influenza virus. Typically, the transmission occurs through direct hand-to-mouth contact with surfaces contaminated with droplets, rather than direct mucous membrane contact splatter from sneezes or coughs.
    [Show full text]
  • On the Effect of the Respiratory Droplet Generation Condition On
    fluids Article On the Effect of the Respiratory Droplet Generation Condition on COVID-19 Transmission Ali Hosseinpour Shafaghi 1,2, Farzad Rokhsar Talabazar 1,2 , Ali Ko¸sar 1,2,3,* and Morteza Ghorbani 2,3,4,* 1 Mechatronics Engineering Program, Faculty of Engineering and Natural Science, Sabanci University, Tuzla 34956, Istanbul, Turkey; [email protected] (A.H.S.); [email protected] (F.R.T.) 2 Nanotechnology Research and Application Center, Sabanci University, Tuzla 34956, Istanbul, Turkey 3 Center of Excellence for Functional Surfaces and Interfaces for Nano-Diagnostics (EFSUN), Sabanci University, Orhanli, Tuzla 34956, Istanbul, Turkey 4 Department of Biomedical Engineering and Health Systems, KTH Royal Institute of Technology, SE 141 57 Stockholm, Sweden * Correspondence: [email protected] (A.K.); [email protected] (M.G.) Received: 19 June 2020; Accepted: 14 July 2020; Published: 16 July 2020 Abstract: Coronavirus (COVID-19) is a highly infectious viral disease and first appeared in Wuhan, China. Within a short time, it has become a global health issue. The sudden emergence of COVID-19 has been accompanied by numerous uncertainties about its impact in many perspectives. One of major challenges is understanding the underlying mechanisms in the spread of this outbreak. COVID-19 is spread similar to the majority of infectious diseases through transmission via relatively large respiratory droplets. The awareness of the dispersal of these droplets is crucial in not only improving methods for controlling the dispersion of COVID-19 droplets, but also in discovering fundamental mechanisms of its transmission. In this study, a numerical model is developed to study the motion of droplets expelled through the respiratory system.
    [Show full text]
  • Influenza Sampler
    Influenza Sampler Presenting sample chapters on influenza from the Manual of Clinical Microbiology, 12th Edition, Chapter 86 “Influenza Viruses” by Robert L. Atmar This chapter discusses seasonal influenza strains as well as novel swine and avian influenza strains that can infect people and have pandemic potential. Chapter 83 “Algorithms for Detection and Identification of Viruses” by Marie Louise Landry, Angela M. Caliendo, Christine C. Ginocchio, Randall Hayden, and Yi-Wei Tang This chapter outlines technological advances for the diagnosis of viral infections. Chapter 113 “Antiviral Agents” by Carlos A.Q. Santos and Nell S. Lurian This chapter reviews antiviral agents approved by FDA and their mechanism(s) of action. Photo Credit: CDC/ Douglas Jordan, Dan Higgins Influenza Viruses* ROBERT L. ATMAR Send proofs to: Robert L. Atmar Email: [email protected] and to editors: [email protected] [email protected] [email protected] 86 TAXONOMY The segmented genome of influenza viruses allows the The influenza viruses are members of the family Orthomyxo- exchange of one or more gene segments between two viruses viridae. Antigenic differences in two major structural pro- when both infect a single cell. This exchange is called teins, the matrix protein (M) and the nucleoprotein (NP), genetic reassortment and results in the generation of new and phylogenetic analyses of the virus genome are used to strains containing a mix of genes from both parental viruses. separate the influenza viruses into four genera within the Genetic reassortment between human and avian influenza family: Influenzavirus A, Influenzavirus B, Influenzavirus C, virus strains led to the generation of the 1957 H2N2 and and Influenzavirus D.
    [Show full text]
  • Fluid Dynamics of Respiratory Infectious Diseases
    Fluid Dynamics of Respiratory Infectious Diseases The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Bourouiba, Lydia et al. "Fluid Dynamics of Respiratory Infectious Diseases." Annual Review of Biomedical Engineering 23, 1 (July 2021): 547-577. © 2021 Annual Reviews As Published http://dx.doi.org/10.1146/annurev-bioeng-111820-025044 Publisher Annual Reviews Version Final published version Citable link https://hdl.handle.net/1721.1/131115 Terms of Use Creative Commons Attribution 4.0 International license Detailed Terms https://creativecommons.org/licenses/by/4.0/ Annual Review of Biomedical Engineering Fluid Dynamics of Respiratory Infectious Diseases Lydia Bourouiba The Fluid Dynamics of Disease Transmission Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; email: [email protected] Annu. Rev. Biomed. Eng. 2021. 23:547–77 Keywords The Annual Review of Biomedical Engineering is host-to-host transmission, infectious diseases, masks, ventilation, aerosols, online at bioeng.annualreviews.org airborne, social distancing, multiphase flows, turbulence, fragmentation, https://doi.org/10.1146/annurev-bioeng-111820- COVID-19 025044 Copyright © 2021 by Annual Reviews. This work is Abstract Annu. Rev. Biomed. Eng. 2021.23:547-577. Downloaded from www.annualreviews.org licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted The host-to-host transmission of respiratory infectious diseases is funda- use, distribution, and reproduction in any medium, mentally enabled by the interaction of pathogens with a variety of fluids (gas provided the original author and source are credited. or liquid) that shape pathogen encapsulation and emission, transport and Access provided by Massachusetts Institute of Technology (MIT) on 07/19/21.
    [Show full text]
  • Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings Last Update: July 2019
    Accessable version: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings Last update: July 2019 Jane D. Siegel, MD; Emily Rhinehart, RN MPH CIC; Marguerite Jackson, PhD; Linda Chiarello, RN MS; the Healthcare Infection Control Practices Advisory Committee Acknowledgement: The authors and HICPAC gratefully acknowledge Dr. Larry Strausbaugh for his many contributions and valued guidance in the preparation of this guideline. Suggested citation: Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html Page 1 of 206 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007) Healthcare Infection Control Practices Advisory Committee (HICPAC): Chair PERROTTA, Dennis M. PhD., CIC Patrick J. Brennan, MD Adjunct Associate Professor of Epidemiology Professor of Medicine University of Texas School of Public Health Division of Infectious Diseases Texas A&M University School of Rural Public University of Pennsylvania Medical School Health Executive Secretary PITT, Harriett M., MS, CIC, RN Michael Bell, MD Director, Epidemiology Division of Healthcare Quality Promotion Long Beach Memorial Medical Center National Center for Infectious Diseases
    [Show full text]
  • COVID-19 Routes of Transmission – What We Know So
    SYNTHESIS 06/30/2021 Additional Routes of COVID-19 Transmission – What We Know So Far Introduction Public Health Ontario (PHO) is actively monitoring, reviewing and assessing relevant information related to Coronavirus Disease 2019 (COVID-19). “What We Know So Far” documents provide a rapid review of the evidence on a specific aspect or emerging issue related to COVID-19. Updates in Latest Version This updated version replaces the December 1, 2020 version COVID-19 Routes of Transmission – What We Know So Far.1 The update version focuses on evidence from systematic reviews and meta-analyses, as the body of evidence for each mode of transmission has increased since the last version. This version does not include transmission through respiratory droplets or aerosols, as PHO has recently published COVID-19 Transmission through Large Respiratory Droplets and Aerosols…What We Know So Far (May 21, 2021).2 Key Findings Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted primarily at short range through respiratory particles that range in size from large droplets to smaller droplets (aerosols);2 however, other transmission routes are possible: SARS-CoV-2 can survive on a variety of surfaces, potentially leading to transmission via fomites; however, epidemiological evidence supporting fomite transmission is limited. Transmission through the ocular surface is a possible route of transmission of SARS-CoV-2 based on the detection of viral RNA in ocular samples and limited epidemiological evidence that eye protection decreases the risk of infection. There is evidence for vertical intrauterine transmission of SARS-CoV-2 from mother to child; however, intrauterine transmission is uncommon.
    [Show full text]
  • Project Firstline Facilitator Toolkit Guide Pdf Icon[PDF – 22
    Project Firstline Facilitator Toolkit Guide CS 323152-A Contents Introduction ............................................................................... 3 Overview of Project Firstline ............................................................ 3 Inside Infection Control by CDC’s Project Firstline Video Series .................................. 4 Inside Infection Control Video Series ........................................................... 4 Session Plans and Toolkit Content ...................................................... 5 Session Plans ........................................................................... 5 Toolkit Content ......................................................................... 5 Facilitator Responsibilities ............................................................... 6 Building a Session ........................................................................ 7 Time Factors ............................................................................ 7 Preparing and Conducting a Session ................................................... 8 Understanding Your Audience ........................................................... 8 You Have the Floor ...................................................................... 9 Pay Attention ........................................................................... 9 Encourage Participation ................................................................. 9 Tell Me More ...........................................................................10 Adult
    [Show full text]